Immunoglobulins Market Players Launch New Labs With Growth From Increase In Geriatric Population

The Business Research Company’s Immunoglobulins Global Market Report 2021: COVID-19 Implications And Growth

LONDON, GREATER LONDON, UK, August 26, 2021 /EINPresswire.com/ -- The geriatric population is at high risk of infectious diseases and auto-immune diseases. The immunoglobulin test determines the body's ability to produce antibodies that protect it from bacteria, viruses, and allergies. According to the United Nations department of economic and social affairs (UN DESA), in 2020, the number of people aged over 65 was 727 million globally. By 2050, this figure is expected to have more than doubled, reaching over 1.5 billion people. The aging population is expected to rise from 9.3% in 2020 to 16% in 2050.

The launch of new offices and laboratories to boost research and development activities is shaping the immunoglobulins market. Major companies operating in the immunoglobulins sector are focused on opening new laboratories for immunoglobulins to enhance the platform technology, pipeline development, and manufacturing capabilities. For instance, in February 2021, VectorY, a fully integrated gene therapy firm, has opened offices and laboratories in the Netherlands to develop novel vectorized antibodies for muscular and neurological illnesses. In this laboratory, VectorY creates exclusive and collaborative projects based on a revolutionary AAV platform and antibody-based targeted degradation technology. The company is developing a pipeline of new vectorized antibodies to treat muscle and CNS illnesses, to enhance delivery, durability, and accessibility of specific tissues and cells, to overcome the limits of present therapies.

Read More On The Global Immunoglobulins Market Report:
https://www.thebusinessresearchcompany.com/report/immunoglobulins-global-market-report

The global immunoglobulins market size is expected to grow from $12.89 billion in 2020 to $14.56 billion in 2021 at a compound annual growth rate (CAGR) of 13%. The change in growth trend of the immunoglobulins market is mainly due to the companies stabilizing their output after catering to the demand that grew exponentially during the COVID-19 pandemic in 2020. The immunoglobulins market is expected to reach $19.36 billion in 2025 at a CAGR of 7.4%.

Major players in the immunoglobulins industry are Baxter International Inc., CSL Behring LLC, Grifols S.A., Octapharma, China Biologic Products Inc., Kedrion S.p.A., LFB group, Biotest AG, Sanquin, ADMA Biologics, Option Care Enterprises, and Shanghai Raas Blood Products Co. Ltd.

The main types of products in immunoglobulins are IgG, IgA, IgM, IgE, and IgD. Immunoglobulin G (IgG) is the primary stimulator of humoral immunity in extracellular fluids such as blood, lymph, and saliva. The immunoglobulins are delivered using the intravenous mode of delivery, subcutaneous mode of delivery and are used in hypogammaglobulinemia, chronic inflammatory demyelinating polyneuropathy (CIDP), immunodeficiency disease, myasthenia gravis, idiopathic thrombocytopenic purpura (ITP), others.

Immunoglobulins Global Market Report 2021 - By Product (IgG, IgA, IgM, IgE, IgD), By Mode Of Delivery (Intravenous, Subcutaneous), By Application (Hypogammaglobulinemia, Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Immunodeficiency Disease, Myasthenia Gravis, Idiopathic Thrombocytopenic Purpura (ITP)), COVID-19 Implications And Growth is one of a series of new reports from The Business Research Company that provides immunoglobulins market overview, forecast immunoglobulins market size and growth for the whole market, immunoglobulins market segments, and geographies, immunoglobulins market trends, immunoglobulins market drivers, restraints, leading competitors’ revenues, profiles, and market shares.

Request For A Sample Of The Global Immunoglobulins Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=5284&type=smp

Here Is A List Of Similar Reports By The Business Research Company:

Autoimmune Disease Diagnosis Global Market Report 2021 - By Product (Consumables & Assay Kits, Instruments), By Test Type (Routine Laboratory Tests, Autoantibodies Tests, Immunologic Tests), COVID-19 Growth And Change
(https://www.thebusinessresearchcompany.com/report/autoimmune-disease-diagnosis-market-global-report-2020-30-covid-19-growth-and-change)

Research Antibodies And Reagents Global Market Report 2021: COVID-19 Growth And Change To 2030
(https://www.thebusinessresearchcompany.com/report/research-antibodies-and-reagents-global-market-report-2020-30-covid-19-growth-and-change)

Scientific Research And Development Services Global Market Report 2021 - By Type (Social Sciences And Humanities Services, Physical, Engineering, And Life Sciences, Nanotechnology Services, Biotechnology Services), COVID-19 Impact And Recovery
(https://www.thebusinessresearchcompany.com/report/scientific-research-and-development-services-global-market-report-2020-30-covid-19-impact-and-recovery)

Interested to know more about The Business Research Company?
The Business Research Company is a market research and intelligence firm that excels in company, market, and consumer research. It has over 200 research professionals at its offices in India, the UK and the US, as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.

Read more about us at https://www.thebusinessresearchcompany.com/about-the-business-research-company.aspx

Or get a quick glimpse of our services here: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Call us now for personal assistance with your purchase:
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293

The Business Research Company
Email: info@tbrc.info
Follow us on LinkedIn: https://bit.ly/3b7850r
Follow us on Twitter: https://bit.ly/3b1rmjS
Check out our Blog: http://blog.tbrc.info/

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info@tbrc.info
Visit us on social media:
Facebook
Twitter
LinkedIn